{
    "nctId": "NCT02670603",
    "briefTitle": "A Trial of Evonail\u00ae Solution for Prevention or Treatment of Onycholysis",
    "officialTitle": "A Prospective Randomized Controlled Trial of Evonail\u00ae Solution for Prevention or Treatment of Onycholysis in Breast Cancer Patients Who Received Neoadjuvant/Adjuvant Docetaxel Chemotherapy",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Docetaxel Chemotherapy",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "The incidence of onycholysis Gr 2 or more",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with breast cancer receiving adjuvant/neoadjuvant docetaxel chemotherapy\n\nExclusion Criteria:\n\n* Patients with breast cancer receiving palliative docetaxel chemotherapy\n* Patients having onycholysis before docetaxel treatment",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}